📖

map6

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-map6

Related Entities

Metadata

slug	genes-map6
entity_type	gene
kg_node_id	MAP6

Linked Artifacts (88)

mentions🧪Tau-Independent Microtubule Stabilization via MAP6 Enhanceme90%

targets🧪Tau-Independent Microtubule Stabilization via MAP6 Enhanceme90%

analysis_target🔬What are the mechanisms underlying selective vulnerability o80%

mentions🧫MAP6 depletion effects on neuronal development in primary cu80%

mentions🧫In vivo neuronal migration assay with MAP6 depletion80%

mentions🧫MAP6 depletion effects on neuronal development in primary cu80%

mentions🧫Double depletion rescue experiment: tau and MAP6 co-depletio80%

mentions🧪Tau-Independent Microtubule Stabilization via MAP6 Enhanceme80%

related🧪Tau-Independent Microtubule Stabilization via MAP6 Enhanceme80%

related🧫MAP6 depletion effects on neuronal development in primary cu72%

related🧫In vivo neuronal migration assay with MAP6 depletion72%

related🧫MAP6 depletion effects on neuronal development in primary cu72%

related🧫Double depletion rescue experiment: tau and MAP6 co-depletio72%

mentions🔬What are the mechanisms underlying selective vulnerability o70%

mentions🧫Axonal Transport Dysfunction Validation in Parkinson's 70%

mentions🧫Prion Strain Diversity and Selective Vulnerability70%

mentions🧫4R-Tau Targeting Therapies for PSP and CBS70%

mentions🧫Anti-Tau Immunotherapy Dosing Optimization70%

mentions🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy70%

mentions🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri70%

mentions🧫Blood Biomarker vs Tau PET for Treatment Monitoring70%

mentions🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi70%

mentions🧫Tau Co-Pathology in DLB Clinical Heterogeneity70%

mentions🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers70%

mentions🧫PSP and CBS Biomarker Validation Study70%

mentions🧫Tau Pathology Initiation Zone Identification70%

mentions🧫Tau Propagation Causality Test — Does Tau Spread Drive Neuro70%

mentions🧫Tau Spreading Network Mapping via Spatial Transcriptomics in70%

related🔬What are the mechanisms underlying selective vulnerability o70%

related🧫Macroautophagy Dysfunction in PD - Experiment Design70%

related🔬What are the mechanisms underlying selective vulnerability o70%

related🧫Macroautophagy Dysfunction in PD - Experiment Design70%

related🧫Axonal Transport Dysfunction Validation in Parkinson's 70%

related🧫Prion Strain Diversity and Selective Vulnerability70%

see_also🧪Tau-Independent Microtubule Stabilization via MAP6 Enhanceme70%

mentions🔬What are the mechanisms underlying selective vulnerability o63%

related🧫Axonal Transport Dysfunction Validation in Parkinson's 63%

related🧫Prion Strain Diversity and Selective Vulnerability63%

related🧫4R-Tau Targeting Therapies for PSP and CBS63%

related🧫Anti-Tau Immunotherapy Dosing Optimization63%

related🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy63%

related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri63%

related🧫Blood Biomarker vs Tau PET for Treatment Monitoring63%

related🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi63%

related🧫Tau Co-Pathology in DLB Clinical Heterogeneity63%

related🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers63%

related🧫PSP and CBS Biomarker Validation Study63%

related🧫Tau Pathology Initiation Zone Identification63%

related🧫Tau Propagation Causality Test — Does Tau Spread Drive Neuro63%

related🧫Tau Spreading Network Mapping via Spatial Transcriptomics in63%

see_also📖c1q60%

see_also📖Packard Center for ALS Research60%

see_also📖HCN1 Gene60%

see_also📖idh260%

see_also📖Excitotoxicity60%

see_also📖DAB1 Gene60%

see_also📖Accelerating Medicines Partnership for Alzheimer's Dise60%

see_also📖Genes60%

mentions🧪Programmable Neuronal Circuit Repair via Epigenetic CRISPR50%

mentions🧫4R-Tau Targeting Therapies for PSP and CBS50%

mentions🧫Anti-Tau Immunotherapy Dosing Optimization50%

mentions🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy50%

mentions🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri50%

mentions🧫Axonal Transport Dysfunction Validation in Parkinson's 50%

mentions🧫Blood Biomarker vs Tau PET for Treatment Monitoring50%

mentions🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi50%

mentions🧫Tau Co-Pathology in DLB Clinical Heterogeneity50%

mentions🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers50%

mentions🧫Prion Strain Diversity and Selective Vulnerability50%

mentions🧫PSP and CBS Biomarker Validation Study50%

mentions🧫Tau Pathology Initiation Zone Identification50%

mentions🧫Tau Propagation Causality Test — Does Tau Spread Drive Neuro50%

mentions🧫Tau Spreading Network Mapping via Spatial Transcriptomics in50%

related🧫s:** - Test whether HCN1 knockout specifically in EC layer I50%

related🧫s:** - Test MCU overexpression specifically in layer II neur50%

related🔬Analyze circuit-level changes in neurodegeneration using All50%

related🔬CRISPR-based therapeutic approaches for neurodegenerative di50%

related🧪Quantum Coherence Disruption in Cellular Communication50%

mentions🔬Analyze circuit-level changes in neurodegeneration using All40%

related🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem40%

related🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener40%

related🧪Perforant Path Presynaptic Terminal Protection Strategy40%

related🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati40%

related🧪Reelin-Mediated Cytoskeletal Stabilization Protocol40%

related🧪HCN1-Mediated Resonance Frequency Stabilization Therapy40%

related🔬Why do entorhinal cortex layer II stellate neurons die first40%

mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di35%